ACHE and cystic fibrosis: Cholinergic signaling is already being investigated as a therapeutic target for diseases of intestinal inflammation such as IBD26,27,55 which shares many GI symptoms with CF 56,57 This work suggests AChE inhibition may also be therapeutically beneficial for patients with CF as well.